Literature DB >> 31082426

Profiling of differentially expressed genes in cadmium-induced prostate carcinogenesis.

Venkatesh Kolluru1, Ashish Tyagi1, Balaji Chandrasekaran1, Chendil Damodaran2.   

Abstract

The aim of the present study was to investigate the genetic signatures of cadmium-transformed prostate epithelial (CTPE) cells and to identify the potential molecular signaling involved in their malignant transformation. The dataset contained normal prostate epithelial (RWPE-1) and CTPE cells. To further examine the biological functions of the identified differentially expressed genes (DEGs), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome pathway enrichment analyses were performed. In total, 2357 DEGs were identified, including 1083 upregulated genes and 1274 downregulated genes. GO, KEGG, and Reactome pathway enrichment analyses indicated that upregulated genes were significantly enriched in ECM-receptor, focal adhesion, TGFβ signaling, and syndecan interactions, while downregulated genes were mainly involved in cell cycle regulation, arachidonic acid metabolism, oxidative phosphorylation, and folate biosynthesis (p < .05). The top upregulated (SATB1 (p < .0001), EYA2 (p < .0001) and KPNA7 (p < .0027)) and downregulated (PITX2 (p < .0007), PDLIM4 (p < .0020) and FABP5 (p < .0007)) genes were further validated via qRT-PCR analysis. In conclusion, the present study profiled DEGs in RWPE-1 and CTPE cells and identified gene pathways that may be associated with malignant transformation and tumor progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cadmium; Differential gene expression; Enrichment; KEGG; Prostate cancer

Year:  2019        PMID: 31082426      PMCID: PMC6554726          DOI: 10.1016/j.taap.2019.05.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  71 in total

1.  Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.

Authors:  P Joseph; T K Muchnok; M L Klishis; J R Roberts; J M Antonini; W Z Whong; T Ong
Journal:  Toxicol Sci       Date:  2001-06       Impact factor: 4.849

2.  Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate.

Authors:  M P Waalkes; M Anver; B A Diwan
Journal:  Toxicol Sci       Date:  1999-12       Impact factor: 4.849

3.  Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes.

Authors:  M P Waalkes; M R Anver; B A Diwan
Journal:  J Toxicol Environ Health A       Date:  1999-10-29

4.  ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).

Authors:  Julio A Aguirre-Ghiso; Yeriel Estrada; David Liu; Liliana Ossowski
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

5.  Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study.

Authors:  B Pesch; J Haerting; U Ranft; A Klimpel; B Oelschlägel; W Schill
Journal:  Int J Epidemiol       Date:  2000-12       Impact factor: 7.196

6.  The German Environmental Survey 1990/1992 (GerES II): cadmium in blood, urine and hair of adults and children.

Authors:  K Hoffmann; K Becker; C Friedrich; D Helm; C Krause; B Seifert
Journal:  J Expo Anal Environ Epidemiol       Date:  2000 Mar-Apr

7.  Exposure of the U.S. population aged 6 years and older to cadmium: 1988-1994.

Authors:  D C Paschal; V Burt; S P Caudill; E W Gunter; J L Pirkle; E J Sampson; D T Miller; R J Jackson
Journal:  Arch Environ Contam Toxicol       Date:  2000-04       Impact factor: 2.804

8.  Cadmium-induced malignant transformation of human prostate epithelial cells.

Authors:  W E Achanzar; B A Diwan; J Liu; S T Quader; M M Webber; M P Waalkes
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

9.  Cadmium is a mutagen that acts by inhibiting mismatch repair.

Authors:  Yong Hwan Jin; Alan B Clark; Robbert J C Slebos; Hanan Al-Refai; Jack A Taylor; Thomas A Kunkel; Michael A Resnick; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

Review 10.  A global perspective on cadmium pollution and toxicity in non-occupationally exposed population.

Authors:  Soisungwan Satarug; Jason R Baker; Supanee Urbenjapol; Melissa Haswell-Elkins; Paul E B Reilly; David J Williams; Michael R Moore
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

View more
  2 in total

1.  Protective Role of 4-(4-Hydroxy-3-methoxyphenyl)-2-Butanone on Prostatic Cells Hyperplasia of Rats and Human, 5α-reductase Inhibition Pathway.

Authors:  Ahmed S Ahmed; Mohamed Gaber Soliman
Journal:  J Microsc Ultrastruct       Date:  2021-05-24

Review 2.  FABP5 as a novel molecular target in prostate cancer.

Authors:  Saoirse Elizabeth O'Sullivan; Martin Kaczocha
Journal:  Drug Discov Today       Date:  2020-09-20       Impact factor: 7.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.